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The fulldength eDNA of a neutrophil antibiotic dodecapeptide has been cloned by rever~e transenptmn/PCg from bovine bone marrow RNA. 
This peptlde was originally i~olated from bovine neutrophils, and shown to exert a potent antimicrobial ctivity in vitro on both l~nchertchia coil 
and Staphylococcus aureus. The eDNA codes for a polyrmptlde of 155 amino acid residues with a predicted mass of 17,629 Da and a pl or 8 03. 
The deduced sequence comprises a putative signal peptlde of 29 amino acids, a 114 residue pro-region, and a earboxy-lenninal dodecapeptide 
corresponding to the mature antibiotic. The pro-sequence displays extensive idenuty to corresponding regtons of other structurally unrelated 
anub~otic peptides of bovine neutrophils recently cloned. 
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1, INTRODUCTION 
A central role of neutrophils in the initial host re- 
sponse to microbial challenge is testified by a massive 
recruitment of" these cells at the infection site, followed 
by rapid and effective pathogen inactivation. Killing is 
ensured by the production of  highly reactive oxygen 
derivatives [1] combined with the release of granule- 
associated cytotoxic proteins into phagocytic vacuoles 
[2,3]. Oligo- and polypeptides with diverse antimiero- 
bial spectra have been isolated from neutrophils of var- 
ious animal species [4-7]. In particular, from granule 
extracts of bovine neutrophils, four cationic peptides 
have been purified and characterized. Two of them, 
associated as inactive proforrns to the large granules 
[8,9], are known as Bar5 and Bar7, and exhibit bacteri- 
cidal activity mainly, but not exclusively, on Gram- 
negative organisms [10,11]. In addition to these, a cyclic 
dodecapeptide, previously named bactenecin [12], and 
a Trp-rich tridecapeptide amide named indolicidin [13], 
exert a potent antibacterial action on both Eschertchia 
coli and Staphylococcus aureua. We report here the nu- 
cleotide sequence of a full-length eDNA encoding the 
precursor form of the cyclic dodecapeptide. The eDNA 
cloning of Bar5 [14] and indolieidin [15] has recently 
shown that these antibiotics share highly similar pro- 
sequences. A homologous pro-sequence is also pre- 
dicted to precede the sequence of the dodeeapeptide. 
Although the mature forms of all these peptides appear 
structurally unrelated, they are likely to derive from a 
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common gene family also including members isolated 
from different animal species [16,17]. 
2. EXPERIMENTAL 
2.1. eDNA ctomng 
Total RNA wa.~ extracted from bovine bone marrow mils with 
8uanidinium t hioeyanate [18]. The rapid amphfication feDNA ends, 
or RACE, [19] was used to obtain both the 3' and 5' ends of the 
dodecapeptide eDNA. To generate the 3' end, the first strand eDNA 
was synthesized using 1 ,ug of total RNA and 1.5 ng of primer adaptor 
5"-TCGGATCCCTCGAGAAOC(dT i 8)-3' and Moloney m urine leu- 
kemia virus (M M LV) reverse transcripmse (Bethesda Research Labo- 
ratorms. Gmthersburg, MD) (1 h at 40°C). The reaction mixture (20 
/tl) was then heated to 95°C and 80/el of the PCR baiter (10 mM 
Tris-HCl, pH 8.3. 50 mM KCI. 1.5 mM MBCI_,) were added with S0 
pmol of both the upstream ohgonucleot,de 5".CGCGAATT- 
CAAAGCCTGTGAGCTTC-3' and the downstream primer adaptor 
5'-CGAGCTCGGATCCCTCGAOAAGCTT-3'. PER was carried 
oat wah 2 5 U of Taql polymerase (Perkin-Elmer-Cetus. Norwalk. 
CT) for 30 cycles of d~naturation at 94°C for 2 mm, annealing at55* C 
for 1 min and polymerization at 72°C for 2 mix. 
The RACE to the 5" end was carried out using the oligonucleotide 
5'-CAOATCCAGTAGCTTGAGGC-Y derived from the 3' end se- 
quence of the dod¢capeptide. Single-strand~l eDNA was tailed using 
terminal deoxynucleotldyl transferase (Bethesda Research Laborato- 
ries) and dG'l'P. Amplification conditions were as above, using an 
upstream primer complementary to the dGTP tall (dCl5), and a 
downstream primer 5"-GACGAATTCGAGTAAGAAAACCCTTA- 
3~. 
2.2. eDNA sequencing attd sequence attalyats 
The amplified eDNA wa~ cloned in Bluesctipt KS* v~ctor (Strat- 
agene, San Diego, CA). S,zqaencing was performed on both strands 
with the dldeoxy chain-termination method [20]. Regions with high 
G+C content were also sequenced in parallel with deazaguanosine and 
automated flume~cent DNA ~queneing (EMBL flaon.~,cent DNA 
sequencer, Heidell~rg, Germany). Analysi~ of the DNA sequence was 
conducted with the ald of the lntelliGenetics Suite version 5.4 (lntelh- 
Genetics Inc., Mountain View, CA), and the homology search was 
Pubhshed by EIsevler Science PublLshers B.V ! 87 
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carried out on the Swi~s-Prot database The hydropathy plot wan 
produced by the method of Kyt¢ and Doolittle [21] w~th a w~dth of 
9 residues, 
2.3. Northern analysts 
Total RNA (10/ag) was separated by elcctrophore~is on 9.41 M 
formaldehydell% agaroue gels, transferred to a nylon t,,embrane 
(Zeta-Probe GT, B,o-Rad, Richmond, CA) by the downward alkaline 
eapdlary method [22], ero~slinked w~th UV.Stratalinker (Stratagen¢), 
and hybridized (60°C, 0.5 M NaPi, 7% SDS, 1 mM EDTA, 16 h) with 
a eDNA re-~triction fragment, ~ap labelled by random primer synthesis 
(Pharmacia-LKB, Upp~ala, Sweden). 
2.4. lu vitro transcription attd translation 
I/zg of the Blucscript KS* plasmid containing the full-length eDNA 
insert was linearized and transcribed with T7 RNA polymerase inthe 
presence of the cap analogue (Phammcm) In wtto translation wa~ 
conducted using a rabbit reuculocyte lysate (Novagene, Madison, 
W1). Translation products were analyzed by IS% SDS-PAGE 
3. RESULTS AND DISCUSSION 
3.1. Cloning of the cycEc dodecapeptide 
Cloning of the cyclic dodeeapeptide from bovine 
bone marrow cells was approached by reverse transcrip- 
tion followed by PCR (RACE protocol) [19]. Using an 
upstream primer identical to a sequence of a Bat5 
eDNA clone [14], and a downstream oligo-dT primer, 
three products of different size were amplified (not 
shown). By sequence analysis these were found to en- 
code the precursor forms of Bae5 [14], indolicidin [15], 
and the cyclic dodeeapeptide, respectively. The three 
fragments revealed homologous 5' regions, incomplete 
at their 5' ends. Northern analysis with a ~P-labelled 
restriction fragment corresponding to a sequence 
unique to the dodecapeptide, r vealed the presence of 
a corresponding mRNA of about 0.6 kb in bovine bone 
marrow RNA (Fig. 1), but not in bovine heart, kidney, 
liver, lung, small intestine, spleen, and stomach (not 
shown). 
The full-length eDNA of the cyclic dodeeapcptide 
was obtained by the 5' RACE [19]. Amplified products 
were cloned in Blu~cript vector. Since the sequences 
anal2ized were found to differ at two positions, 24 clones 
generated from different preparations of RNA were 
completely sequenced in both directions. A guanine was 
found to replace adenine-395 in the translated region of 
18 of the clones, and two additional adenine nueleotides 
were found inserted at position 513 of the Y-untrans- 
lated region of 9 random clones (Fig. 2). 
3.2. Features of the p,'edicted sequence 
The full-length eDNA of the cyclic dodeeapeptide 
(Fig. 2) shows a putative translation stat~t eodon at po- 
sition 13 and a stop codon at position 478. The poly(A) 
tail is preceded by a consensus ignal. The sequence 
predicts a protein (pre-prododecapeptide) of 155 amino 
acid residues, with a calculated mass of 17,629 Da, con- 
firmed by in vitro translation of the transcript (not 
shown), and an overall pI of 8.03. No N-linked glyeosyl- 
ation sites are present in the predicted sequence. A hy- 
drophobic stretch (amino acid residues 1-29) typical of 
a signal sequence, including a consensus signal peptid- 
AGACTGGGCACC 
13 A~GGAGACCCCGAGGGCCA~CTC~CCCT~GGAC~G~GTCACTG~GG 
Y ~ T P R A ~ L S L G R W S L W  16 
61 CTGC'rGCTGCTGROACTAGCGCTGCCC~CGGCCAGCGCCCAGGCCCTC 
L L L L G I A L P S A S A ~ Q ~ L  3~ 
109 AGC?ACAGG~GGCCG?GC~CGTGCTGTGGATCAGCTC~GC~ 
S Y R E A V L R A V D Q L N E Q 48 
157TCCTCAG~CCT~CAT~ACCG~CTTC~'C~AGCTGGACCA~CCTCCT 
S S ~ P N ~ Y R L L ~ L O Q ~  G4 
205 CAGGATGATG~GACCCAGACAGCCCG~GCGGG'?GAGCTT~GGGTG 
Q D D ~ D P D S P M R V S F R V  80 
253 ~GGAGACCGTGTGCTCCAGGACCACCCAGCAGCCCCCCGAGCAGTG? 
M Z T V e S ~ ' ~ ' T Q Q P P ~ Q C  96 
301 GACTTC~GGAG~TGGGCTGCTGAAACGCTGTGAGGGGACAGTCACC 
D F K ~ N G L L ~ R ~ E G T V T  Ii~ 
349CTGGACCAGG?CAGGGGT~CTTCGACATCACCTGT~T~TCACCAG 
L D O V R G N F D ~ T e ~| N H Q 128 
397 AGCATCAGGA~A~AAAGCAGCCATGGGCACCACCA~AGGCAGCCCGA 
S ~ R ~ T M O P W A P ~ O A A . / ~ _ I 4 4  
445 TTATGTCGCATT~TAGTGAT~%~GG~GCAGAT~TCAGCT&TTGTA 
T, ¢ ~ T v ~ T ~ ~ Q ~ * 155 
493 GAT~C~GTCA'P~GCCAGCA'~GAGTCCT~GGGqTTTCTTACTCTGCC 
541 TCAAGCTACTGGATCTGAAA~'~CTTGT~CATG (A)n 
288 
188 . - -  
a 
Fig. 1. Northern analysis. A Northern blot oftotal RNA from bovine 
bone marrow cells was probed with a ~"P-lal~lled restriction fragment 
corresponding to nucleotides 419-535 of the dodecapepude eDNA 
sequent. This recognizes a mRNA of about 0.6 kb 
= I 3' 
Fig. 2. Nucleotide and deduced amino acid sequence of the cyclic 
dodccapeptide precursor, and partial restriction endonuclease map of 
the eDNA. The nucleotide bcquene¢ is numbered on the left. The 
amino acid sequen~ is numbered from the first methionme on the 
right. The signal sequence tsoverlined, the arrow indicates the putatw= 
cleavage site lbr ~ignal p~ptldase. The sequence of the mature antibi- 
otic m underlined, aild the stop codon is marked with an asterisk. The 
polyadcnylation signal is double underhned. Cystemes are in bold. A 
schematic representation f the full-length eDNA of the dodccapep- 
tide is shown at the bottom. 
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F~g. 3. Hydropathy plot [21] of the cyclic dodecapcpdde precursor. 
Linear diagram of the deduced amino acid sequence, w~th the amino- 
terminal on the left and the earboxyl.terminal on the right A dashed 
verucal l,,ae shows the cleavage s~te for the maturat,on of the cyclic 
dodecapeptide. The lower panel indicates tile distribution of basic (+) 
and acidtc (-) re~due~. 
ase cleavage site (AIa-X-AIa) [23] is present at the 
amino-terminus of the protein (Fig. 3). The putative 
signal peptide is followed by a 114 amino acid long 
hydrophilic pro-sequence, corresponding to residues 
30-143, which is characterized by a cluster of negatively 
charged amino acids in the region between residues 59 
and 71. The carboxy-terminal dodecapeptide (residues 
144-155) corresponds to the mature antibiotic isolated 
from granule extracts of neutrophils, and exactly 
matches the sequence determined by protein sequencing 
[12]. The two cystcine residues at positions 146 and 154 
are known to maintain the mature antibiotic in a cyclic 
structure by a disulfide bond [12]. In the conformation 
proposed [12], the peptide chain forms a bend at residue 
7, with the hydrophobic residues clustered around the 
bend. This ~otnpaet structure is reminiscent of defen- 
sing, a family of numerous small antimicrobial peptides 
with a characteristic cysteine motif forming three intra- 
molecular disulfide bonds [24]. 
Unlike defensing, which are expressed by various cell 
types of mammals and insects [24], the bovine neutro- 
phil has so far been the only source of the dodecapeptide 
[12]. Recently, another basic, cysteine-rich peptide, with 
functional similarities to both the dcdecapeptide and 
the defensins, has been isolated from bovine tracheal 
mueosa [25]. The sequences of all these cysteine-rich 
peptides, as deduced from their mRNAs, lack the car- 
boxy-terminal g ycine required for amidation, a charac- 
teristic feature of several other antibacterial peptides 
[14,15,26,27], that may be required to increase their 
biostability. The amino-terminus of the dodecapeptide 
is preceded by an Ala residue at position 143. This is a 
likely site of  proteolytie cleavage for elastase, which 
may be responsible for the removal of the pro-sequence 
from the precursor [9]. Due to base substitution, the 
clones analyzed predicted the alternative prcser~ee of 
Gin and Arc at position 128 of the pro-sequence, point- 
ing to the existence of  either a polymorphic, or an addi- 
tional gene. Genomic cloning will resolve this issue, 
since neither possibility can be excluded at present. 
3.3. Observed shnilario' of the dodecapeptide precursor 
with other proteins 
The sequence of the deduced precursor is compared 
in Fig. 4 with that of Bat5 [14] and indolicidin [i 5], both 
isolated from bovine neutrophils. As expected from the 
cloning strategy, the pro-sequence of the dodeeapeptide 
displays extensive identity to corresponding regions of 
D~aee~se~ao ~SLSLSaWSr~LLZLS~aS~Qi£S~a~U~V~Q~~ SS 
Bae5 I METOBA SLSL~ L~LLL L~LVLP SASAQAL SYaEAVLRAVDOP ~],~3 SE~ LYRLL ~ 59 
ooooo°oo , o° . . . . . . . . . . . . . . . . . . . . .  
I - - :  ,,I ~ i l /  
Bat5 IqFDIN~NELOS~r ~rpp l r~ppfypp f rpp ~- rppl fpplrpp frpp igp fp~rr i~6 
F,g. 4. Alignment of tile predicted sequence of tile cychc dodecapeptlde with other antibiotic peplidcs of bovine neatrophil. The amino acid sequence 
deduced from the eDNA encoding the dodecapeptlde is ahBaed with the dedu,.-~d sequences of,ndoheidtn [i 5]. anti Bae5 [i4]. Box,rd r~,dm.~ lellee~. 
those common to the dodecapeptlde and at least one other peptide. Ahgned eysteines are shaded Small etters indicate the sequences corresponding 
to the mature anubiot~es, and asterisks show the earbox:,.-termmal res,dues of the pro-~equence~. Sequences were aligned usin~ the GENALIGN 
program (lntelliGenet,c~). 
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both Bat5 and indoticidin, including 4 invariant cyste- 
ine residues, that may offer possible structural con- 
s~ra~P,'.~. B~',b strl~elura} an~ f~vliona~ ~m#ieafior~s 
have been previously suggested [14] by the presence of 
homologous pro-regions in the sequences of proBac5 
and proindolicidin. The evidence that the cyclic dode- 
capeptide also carries a homologous region further 
strengthens the hypothesis of  a common pro-sequence 
acting as a carrier for defense peptides. In fact, in addi- 
tion to the bovine antibiotics mentioned above, 2 ho- 
mologous proteins from different animal species have 
been identified, providing evidence for a more wide- 
spread presence of this sequence: CAP18, an anti- 
bacterial protein from rabbit [17], and cathelin, an in- 
hibitor ofcathepsin L isolated from pig neutrophils [16]. 
These exhibit about 57% and 66% identity, respectively, 
to the pro-region of the dodeeapeptide (not shown). 
Both proBac 5 and proindohcidin carry a valyl resi- 
due (marked with an asterisk in Fig. 4) at the cleavage 
site for the proteolytic maturation of the respective an- 
tibiotics. The pro-sequence of the dodecapeptide as- 
signes lie at the same position, followed by a stretch of 
13 additional residues (131-143 of the sequence) extend- 
ing its earboxy-terminus. It is not known whether these 
residues are cleaved from the precursor during the intra- 
cellular maturation of the antibiotic, lmmunochemieal 
investigations with antibodies to the dodecapeptide will 
clarify this point. In particular, since the cyclic dode- 
eapeptide has been the only proteolytic product so far 
isolated from neutrophils [12], it will be interesting to 
know whether the same precursor may produce more 
biologically relevant fragments. 
Acktzoa,ledgement~. We thank Dr. D. Romeo for helpful discussion. 
This work was supported by grants from the National Research Coon- 
ell (Progetto Fmalizzato 'BlotecnoloB~e e Blostrumentaz~one') and 
from the Italian Mmintry for University and Research. 
REFERENCES 
[1] Klebanoff, S.J. (1988) in: Inflammation Basic Principles and 
Clinical Correlates (J.l. Gallin, I.M. Goldstein and R. Snyder- 
mann eds.) pp. 391-444, Raven Pre~s, New York. 
~2] Joiner, K.A., Ganz, T, Albert, 3. and Rotrosea, D. (t989} J. Ceil 
BIoL 109, 2771-2"~2. 
{3l Zanetti, M., Liueri, L., Griffiths, G., Gennnro, R. and Romeo, 
D. (1991) I. lmmunol. 146, 4295-4300. 
[4} Eisb~t-h, P. and Weiss, J. (1988) m: Inflammation: Basic Princi- 
ples and Climcal Correlates (J.1. Gallin, I.M. Goldstem and R. 
Snydermann eds,) pp. 391--444 Raven Press, New York. 
[5] Lehrer, R.I and Ganz, T. (1990) Blood 76, 2169-2181. 
[6] Gennaro, R., Romeo, D., Skerlavaj, B. and Zanetti, M. (1991) 
in: Blood Cell Biochmnistry (J.R. Harris ed.) pp. 335-368, Ple- 
num, New York. 
[7] Za~lolT, M. (1992) Curr. Opin. lmmunol. 4, 3-7. 
[8] Zanetti, M., Lltteri, L., Gennaro, R., Horstmann, H. and Romeo, 
D. (1990) J. Cell Biol. I l 1, 1363-1371. 
[9] Scocchi, M., Skerlavaj, B., Romeo, D. and Gennaro, R., Eur. J. 
Blochem. (in press). 
[10] Gennaro, R., Skerlavaj, B. and Romeo, D. (1989) Infect. Imrnun. 
57, 3142-3146. 
[I i] Frank, R.W., Gennaro, R., Schneider, K., Przybyl~ki, M. and 
Romeo, D. (1990) ,i. Biol. Chem. 265, 18871-18874. 
[12] Romeo, D., Skerlavaj, B., Bolognesi, M. and Gennaro, R. (1988) 
J. Biol. Chem. 263, 9573-9575. 
[13] Selsted, M.E., No'cotnj, M.J., Morns, W.L., Tans, Y.-Q., Smith, 
W. and Culler, J.S. (1992) J. Biol. Chem. 267, 4292-4295. 
[14] Zaaetti, M., Del Sal, G., Storiei, P., Schneider, C. and Romeo, 
D. (1993) J. Biol. Chem. (in press). 
[15] Del Sal, (3., Stonci, P., Schneider, C., Romeo, D. and Zanetti, 
M (1992) Biochem. Biophys. Reg. Commun. 187, 467-472. 
[16] Ritonja, A., Kopitar, M., Jerala, R. and Turk, V. (1989) FEBS 
Lett, 255, 211-214. 
[17] Larrick, J.W., Morgan, J.G, Palings, I., Hirata, M. and Yen, M. 
H. (1991) Bloehem. Biophys. Reg. Commun. 179, 170-175. 
[I 8] Chomczi)~ki, P. and Sacchl, I'4. (1987) Anal. Bioehem. 162, 156- 
159. 
[i 9] Frohman, A M., Dush, K.M. and Martin, G.R. (1988) Proe Natl. 
Aead Set. USA 85, 8998-9002. 
[20] Sanger, F., Nlcklen, S. and Coulson, A.R. (1977) Proc. Nail. 
Acad. SoL USA 74, 5403-5467. 
[21] Kyte, J. and Doollttle, R.I. (1982) J. Mol. Biol. t57, 105-132. 
[22] Chomczynski, P. (1992) Anal. Blochem. 201, 134-139. 
[23] von Hedne, (3. (1986) Nucleic Acids Rcs. 14, 4fi83. 
[24] Lehrcr, R.I., Ganz, T. and Selsted, M.E. (1991) Cell 64, 229-230. 
[2.51 Diamond, G., 2~asloff, M, Eck, H., Brassear, M., Maloy, W.L. 
and Bevms, C.L. (1991) Prec. Natl. Acid. Sol. USA 88. 3952- 
3956. 
[26l Agerberth, B., Lee, J., Bergman, T,  Carlquist, M., Boman, I-LG., 
Matt, V. and Jornvall, H. (1991) Ear. 3. Biochem. 202, 849-854. 
[27] Boman, H.G., Boman, I.A., Andreu, D., Zong-qu Li, Merrlfield, 
R.B., Schlenstedt, G. and Zimmerrnann, R. (1989) J. Biol. Chem. 
264, 5852-5860. 
190 
